Supply Issues Medicareplus International Ltd Barrier Film Foam Applicator No Sting ELY532 and ELY533 (ICN 2746)

• The supply issue with Barrier Film Foam Applicator No Sting products from Medicareplus International Ltd is now resolved.
• ELY532 and ELY533 are now available to order through our online catalogue.
• This ICN is now closed.

Change:

• The supplier Medicareplus International Ltd has informed us of a supply issue with its Barrier Film Foam Applicator No Sting products.
• Two product codes are affected in total:
  • ELY532 – Medi Derma S Barrier Film foam applicator no sting 1ml
  • ELY533 – Medi Derma S Barrier Film foam applicator no sting 3ml.
• The supply issue is due to increased demand and lead times; the increased demand is due to supply chain issues on similar products.
• Due to this ongoing supply issue these products are now being threshold managed as they are subject to Protect Demand Management.

Impact:          

• ELY532 and ELY533 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Customers are advised to continue to order in their usual manner and avoid bulk ordering.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 20 December 2024.

Next Steps:               

• Customers are advised to log into our website to view the potential indirect alternative products and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.